Codexis CDXS
NASDAQ CDXS
$1.58 -0.01 (-0.63%)
At close: Aug 20, 2026 · 4:00 PM EDT

Codexis (CDXS) EBT Margin (2010 - 2026)

Codexis (CDXS) posted quarterly EBT Margin of 56.85% for Q1 2026, up 21727.0% year-over-year from N/an in Q1 2025, and down 329.98% quarter-over-quarter from 24.72% in Q4 2025.

Codexis (CDXS) EBT Margin (2010 - 2026) Analysis & Trends

Codexis' EBT Margin history runs 17 years deep, the most recent figure standing at 56.85% for Q1 2026.

  • In Q1 2026, EBT Margin rose 21727.0% year-over-year to 56.85%; the TTM figure through Mar 2026 stood at 40.87% (up 10853.0% YoY), while the FY2025 annual figure was 62.41%, up 4753.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 56.85%, down from 24.72% in the prior quarter.
  • The five-year high for EBT Margin was 24.72% in Q4 2025, with the low at 376.19% in Q3 2023.
  • The 5-year median for EBT Margin is 86.52% (2025), against an average of 131.06%.
  • The sharpest annual moves came in 2023 and 2026: EBT Margin tumbled 34722 bps in 2023, then surged 21727 bps in 2026.
  • Codexis' EBT Margin stood at 62.89% in 2022, then slumped by 128 bps to 143.14% in 2023, then soared by 66 bps to 48.34% in 2024, then surged by 151 bps to 24.72% in 2025, then slumped by 330 bps to 56.85% in 2026.
  • Business Quant data shows CDXS's EBT Margin at 56.85% in Q1 2026, 24.72% in Q4 2025, and 227.96% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 35.61%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 35.71%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -528.97%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 13.77%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -2.67%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -25.06%
10 Codexis 143.86 Mn 88.95 Mn 11.40 Mn -80.42%

Historic Data

Download Data
DateValue
Jun 30, 2026 -80.42%
Mar 31, 2026 -56.85%
Dec 31, 2025 24.72%
Sep 30, 2025 -227.96%
Jun 30, 2025 -86.52%
Mar 31, 2025 -274.12%
Dec 31, 2024 -48.34%
Sep 30, 2024 -160.76%
Jun 30, 2024 -285.06%
Mar 31, 2024 -67.33%
Dec 31, 2023 -143.14%
Sep 30, 2023 -376.19%
Jun 30, 2023 -230.28%
Mar 31, 2023 -174.09%
Dec 31, 2022 -62.89%
Sep 30, 2022 -28.96%
Jun 30, 2022 -6.59%
Mar 31, 2022 -23.62%
Dec 31, 2021 -41.31%
Sep 30, 2021 6.40%